Featured Image

Allows Medical marijuana?: Yes

Allows Adult-Use marijuana?: No

2018 Medical Sales : N/A

2022 Projected Medical Sales : $17,200,000

2018 Adult Use Sales : N/A

2022 Projected Adult Use Sales : N/A

Noteworthy Information: 
{{COVID-19 Update: The state’s medical cannabis dispensaries, or “pharmacies,” allowed to remain open but asked to comply with physical distancing. }}

Utah voters approved Proposition 2 on November 6, 2018, allowing the use of medical marijuana for certain illnesses, such as cancer and PTSD. Patients with a qualifying condition can obtain a recommendation for marijuana from a physician. Facilities will be authorized to grow and sell medical and their licensing and registration fees will fund the program. Smoking cannabis is prohibited. Patients can purchase up to three ounces of cannabis flower or cannabis product that has no more than 20 grams of total composite THC during a 30-day period. Couriers will be licesned for home delivery.

Is there a Regulatory Structure? (State Agency): The Utah Department of Health licenses pharmacies; The Utah Department of Agriculture and Food licenses cultivators and processors.

# of Dispensaries Allowed (# issued): 14; expecting 8 to open by March 2020, the rest by July 2020.

# of Cultivations Allowed (# issued): 10, though they are only planning on allowing 8 to start the program.

# of Manufacturers Allowed (# issued): N/A

# of Testing labs Allowed (# issued): N/A

Geographic Distribution of Licenses: State divided into four geographic regions and have at least one license for each region.

Application Fee: 
Dispensary: $2500

Licensing Fees: 
Dispensary license: $50,000 – $69,500 annually
Courier’s license: $2500 initially, $1000 yearly renewals
Patients: $15 initially, then $5 for 30-day renewal and $15 for 6-month renewals thereafter

Residency Requirements: 
N/A

Vertical Integration Allowed, Required or Prohibited: 
Allowed

Medical Marijuana Qualifying Patient Conditions: 
1. HIV or acquired immune deficiency syndrome
2. Alzheimer’s disease
3. amyotrophic lateral sclerosis
4. cancer
5. cachexia
6. persistent nausea that is not significantly responsive to traditional treatment, except for nausea related to:
– pregnancy
– cannabis-induced cyclical vomiting syndrome
– cannabinoid hyperemesis syndrome
7. Crohn’s disease or ulcerative colitis
8. epilepsy or debilitating seizures
9. multiple sclerosis or persistent and debilitating muscle spasms
10. post-traumatic stress disorder (PTSD) that is being treated and monitored by a licensed health therapist (defined here), and that:
– has been diagnosed by a healthcare provider by the Veterans Administration and documented in the patient’s record; or
– has been diagnosed or confirmed by evaluation from a psychiatrist, doctorate psychologist, a doctorate licensed clinical social worker, or a psychiatric APRN 
11. autism
12. a terminal illness when the patient’s life expectancy is less than six months
13. a condition resulting in the individual receiving hospice care
14. a rare condition or disease that affects less than 200,000 individuals in the U.S., as defined in federal law, and that is not – adequately managed despite treatment attempts using conventional medications (other than opioids or opiates) or physical interventions
15. pain lasting longer than two weeks that is not adequately managed, in the qualified medical provider’s opinion, despite treatment attempts using conventional medications other than opioids or opiates or physical interventions
16. a condition that the compassionate use board approves (once established) on a case-by-case basis

Testing Required: 
Yes

LEAVE A REPLY

Please enter your comment!
Please enter your name here